Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AAPL stock price vs OSCR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OSCR's multiple
Needs OSCR P/E.
Implied fair value · at AAPL's multiple
Needs Annual EPS is negative.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 98% equity / 2% debt · EV / Revenue 8.34x · EV proxy / EBITDA proxy 23.29x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Apple Inc. · implied price per share
Bear
$130.85
Base
$159.76
Bull
$182.30
Oscar Health, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MICROSOFT CORP
AAPL vs MSFT
Alphabet Inc.
AAPL vs GOOGL
Meta Platforms, Inc.
AAPL vs META
NVIDIA CORP
AAPL vs NVDA
INTEL CORP
AAPL vs INTC
CISCO SYSTEMS, INC.
AAPL vs CSCO
Cigna Group
AAPL vs CI
CENTENE CORP
AAPL vs CNC
Elevance Health, Inc.
AAPL vs ELV
HUMANA INC
AAPL vs HUM
UNITEDHEALTH GROUP INC
AAPL vs UNH
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Edwyn research
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe AAPL can sustain its current profitability and deserves a premium multiple indefinitely, then hold or own it for quality, but if you are anchoring to relative valuation, the data argue for avoiding new purchases because AAPL trades far above both OSCR-implied and DCF-based value ranges.
AAPL trades at a massive premium to OSCR on a P/S basis, but the comparison is distorted because OSCR is loss-making while AAPL is highly profitable. Even so, the provided valuation outputs point to a severe disconnect: the current AAPL price of $303.42 versus an implied $19.41 suggests -93.6% downside on OSCR multiple framework.
Supporting Metrics
